Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice

Tomio Narisawa, Yoko Fukaura, Kunihiko Terada, Akiko Umezawa, Noritoshi Tanida, Kazunaga Yazawa, Chikako Ishikawa

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, pravastatin (Pr) and simvastatin (Si), suppressed 1,2-dimethylhydrazine (DMH)-induced colon cancer development in female ICR mice. All mice received an i.p. injection of 10 mg DMH/kg body wt once weekly for 15 weeks. Pr was administered at 0.01, 0.005 and 0.001% levels in drinking water, and Si at 0.01 and 0.002% levels in the diet. All animals had access to Pr or Si throughout the experiments which were terminated at weeks 25 or 30. Histologically most of the tumors were well-differentiated adenocarcinomas. The incidence of colon tumors examined at weeks 25 or 30 was reduced by 67% in the 0.01% Pr group, by 30% in the 0.005% Pr and 0.01% Si groups, and by 24% in the 0.001% Pr and 0.002% Si groups, compared with their respective controls. However, the differences did not reach statistical significance. The number of tumors per mouse was significantly reduced in all groups administered Pr and Si except the 0.001% Pr group as compared to their respective controls. The results from those three independent experiments seem to suggest that HMG-CoA reductase inhibitors may prevent colon tumorigenesis in laboratory animal model.

Original languageEnglish
Pages (from-to)2045-2048
Number of pages4
JournalCarcinogenesis
Volume15
Issue number9
Publication statusPublished - 1994 Sep
Externally publishedYes

Fingerprint

1,2-Dimethylhydrazine
Coenzymes
Pravastatin
Inbred ICR Mouse
Simvastatin
Inhibitor
Mouse
Tumors
Oxidoreductases
Colon
Carcinogenesis
Animals
Tumor
Nutrition
Potable water
Animal Model
Experiments
Statistical Significance
Dimethylhydrazines
Experiment

ASJC Scopus subject areas

  • Cancer Research
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Behavioral Neuroscience

Cite this

Narisawa, T., Fukaura, Y., Terada, K., Umezawa, A., Tanida, N., Yazawa, K., & Ishikawa, C. (1994). Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. Carcinogenesis, 15(9), 2045-2048.

Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. / Narisawa, Tomio; Fukaura, Yoko; Terada, Kunihiko; Umezawa, Akiko; Tanida, Noritoshi; Yazawa, Kazunaga; Ishikawa, Chikako.

In: Carcinogenesis, Vol. 15, No. 9, 09.1994, p. 2045-2048.

Research output: Contribution to journalArticle

Narisawa, T, Fukaura, Y, Terada, K, Umezawa, A, Tanida, N, Yazawa, K & Ishikawa, C 1994, 'Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice', Carcinogenesis, vol. 15, no. 9, pp. 2045-2048.
Narisawa, Tomio ; Fukaura, Yoko ; Terada, Kunihiko ; Umezawa, Akiko ; Tanida, Noritoshi ; Yazawa, Kazunaga ; Ishikawa, Chikako. / Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. In: Carcinogenesis. 1994 ; Vol. 15, No. 9. pp. 2045-2048.
@article{7d789e1464524cd5acf2319022633e3c,
title = "Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice",
abstract = "3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, pravastatin (Pr) and simvastatin (Si), suppressed 1,2-dimethylhydrazine (DMH)-induced colon cancer development in female ICR mice. All mice received an i.p. injection of 10 mg DMH/kg body wt once weekly for 15 weeks. Pr was administered at 0.01, 0.005 and 0.001{\%} levels in drinking water, and Si at 0.01 and 0.002{\%} levels in the diet. All animals had access to Pr or Si throughout the experiments which were terminated at weeks 25 or 30. Histologically most of the tumors were well-differentiated adenocarcinomas. The incidence of colon tumors examined at weeks 25 or 30 was reduced by 67{\%} in the 0.01{\%} Pr group, by 30{\%} in the 0.005{\%} Pr and 0.01{\%} Si groups, and by 24{\%} in the 0.001{\%} Pr and 0.002{\%} Si groups, compared with their respective controls. However, the differences did not reach statistical significance. The number of tumors per mouse was significantly reduced in all groups administered Pr and Si except the 0.001{\%} Pr group as compared to their respective controls. The results from those three independent experiments seem to suggest that HMG-CoA reductase inhibitors may prevent colon tumorigenesis in laboratory animal model.",
author = "Tomio Narisawa and Yoko Fukaura and Kunihiko Terada and Akiko Umezawa and Noritoshi Tanida and Kazunaga Yazawa and Chikako Ishikawa",
year = "1994",
month = "9",
language = "English",
volume = "15",
pages = "2045--2048",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice

AU - Narisawa, Tomio

AU - Fukaura, Yoko

AU - Terada, Kunihiko

AU - Umezawa, Akiko

AU - Tanida, Noritoshi

AU - Yazawa, Kazunaga

AU - Ishikawa, Chikako

PY - 1994/9

Y1 - 1994/9

N2 - 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, pravastatin (Pr) and simvastatin (Si), suppressed 1,2-dimethylhydrazine (DMH)-induced colon cancer development in female ICR mice. All mice received an i.p. injection of 10 mg DMH/kg body wt once weekly for 15 weeks. Pr was administered at 0.01, 0.005 and 0.001% levels in drinking water, and Si at 0.01 and 0.002% levels in the diet. All animals had access to Pr or Si throughout the experiments which were terminated at weeks 25 or 30. Histologically most of the tumors were well-differentiated adenocarcinomas. The incidence of colon tumors examined at weeks 25 or 30 was reduced by 67% in the 0.01% Pr group, by 30% in the 0.005% Pr and 0.01% Si groups, and by 24% in the 0.001% Pr and 0.002% Si groups, compared with their respective controls. However, the differences did not reach statistical significance. The number of tumors per mouse was significantly reduced in all groups administered Pr and Si except the 0.001% Pr group as compared to their respective controls. The results from those three independent experiments seem to suggest that HMG-CoA reductase inhibitors may prevent colon tumorigenesis in laboratory animal model.

AB - 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, pravastatin (Pr) and simvastatin (Si), suppressed 1,2-dimethylhydrazine (DMH)-induced colon cancer development in female ICR mice. All mice received an i.p. injection of 10 mg DMH/kg body wt once weekly for 15 weeks. Pr was administered at 0.01, 0.005 and 0.001% levels in drinking water, and Si at 0.01 and 0.002% levels in the diet. All animals had access to Pr or Si throughout the experiments which were terminated at weeks 25 or 30. Histologically most of the tumors were well-differentiated adenocarcinomas. The incidence of colon tumors examined at weeks 25 or 30 was reduced by 67% in the 0.01% Pr group, by 30% in the 0.005% Pr and 0.01% Si groups, and by 24% in the 0.001% Pr and 0.002% Si groups, compared with their respective controls. However, the differences did not reach statistical significance. The number of tumors per mouse was significantly reduced in all groups administered Pr and Si except the 0.001% Pr group as compared to their respective controls. The results from those three independent experiments seem to suggest that HMG-CoA reductase inhibitors may prevent colon tumorigenesis in laboratory animal model.

UR - http://www.scopus.com/inward/record.url?scp=0027978838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027978838&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 2045

EP - 2048

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -